The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1979, 123: 1822-1828.
Copyright © 1979 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Isaak, D. D.
Right arrow Articles by Cerny, J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Isaak, D. D.
Right arrow Articles by Cerny, J.

Target Cell Heterogeneity in Murine Leukemia Virus Infection

I. Differences in Susceptibility to Infection with Friend Leukemia Virus Between B Lymphocytes from Spleen, Bone Marrow and Lymph Nodes1

Dale D. Isaak2, Joseph A. Price3, Carol L. Reinisch and Jan Cerny

Department of Microbiology, Harvard University School of Public Health, Boston, Massachusetts 02115 and the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115

Abstract

The susceptibility of mouse lymphocytes from various organs to infection by murine leukemia virus (MuLV) (Friend) was studied both in vivo and in vitro by using either Friend virus complex (FV) or lymphatic leukemic virus (LLV), the helper virus isolated from FV. Productively infected cells releasing infectious MuLV were identified as infectious centers (IC) on sarcoma+, leukemia- indicator fibroblasts. IC were detected by days 4 to 6 postinfection in spleen and bone marrow (BM); fewer IC were observed in lymph nodes (LN) and their appearance was delayed until day 8 in FV-infected mice and day 15 in LLV-infected mice. In both groups, the appearance of IC in LN correlated with the onset of splenomegaly (mean = 300 mg) and the development of infection in peripheral blood exceeding 1 x 106 focus-forming units/ml, suggesting that the IC observed in LN were due to dislodged, circulating infected spleen and BM cells rather than due to infection of LN cells. This possibility was tested directly by using a culture system whereby cells from spleen, BM, and LN from normal mice were infected with FV or LLV in vitro. The principal target for MuLV replication in the cultures appeared to be B lymphocytes because 1) stimulation with bacterial lipopolysaccharide (LPS) greatly enhanced the infection of unseparated BALB/c spleen and bone marrow cells, nylon wool-adherent BALB/c spleen cells, and spleen and BM cells from athymic (nude) mice, 2) pretreatment of spleen cells with a heterologous anti-mouse immunoglobulin antiserum plus complement reduced the infection, and 3) the majority of virus-permissive cells in BALB/c spleens were recovered in the pure population of Ig+ cells from an immunoadsorbent column. However, no IC were detectable in LPS-stimulated LN cells from either BALB/c or nude mice, confirming the fundamental difference in susceptibility to the MuLV component of FV between B cells from spleen, BM, and LN suggested by the in vivo studies.

Footnotes

1 This work was supported by United States Public Health Service Grant CA 14922 and American Cancer Society Grant IM-35.

2 Dale D. Isaak received support from Fellowship 1 F32 CA-6122-01 from the National Cancer Institute. Present address, Department of Microbiology and Immunology, Kirksville College of Osteopathic Medicine, Kirksville, Missouri 63501.

3 Present address: Department of Microbiology and Immunology, Duke University Medical Center, Durham, North Carolina 27210.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.